{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:35:10Z","timestamp":1760146510925,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Global Public Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: There is limited evidence comparing hepatitis A seroprevalence among HIV-exposed uninfected (HEU), HIV-infected (HIV), and unexposed uninfected (HUU) children. This compromises rational vaccine decision-making. Methods: This study comprised a retrospective health facility-based population of children aged 1 month\u201312 years. Archival sera were tested for markers of acute (anti-HAV IgM) or past (total anti-HAV) HAV infection. Subgroup analysis was conducted based on perinatal HIV exposure or infection status. Results: Among 513 children, the median age was 10 (IQR: 4\u201325) months. The median maternal age was 29 (IQR: 25\u201334) years. An anti-HAV seropositivity of 95.1% (117\/122 [95% CI 90.2\u201398.4]) was found among those \u22646 months of age, indicative of the rate of transplacental antibody transfer. Among 1\u201312-year-olds, hepatitis A seroprevalence was 19.3% (37\/192 [95% CI 14.1\u201325.7]), while 1.1% (2\/188 [95% CI 0.12\u20132.76]) had evidence of acute infection. Compared to HIV-exposed subgroups (HIV = 60%, 6\/10 [95% CI 27.4\u201386.3] and HEU = 45%, 9\/20 [95% CI 23.8\u201368]), hepatitis A seroprevalence among HUU children was low (29.2%, 47\/161 [95% CI 22.4\u201337.0]). Conclusions: Natural immunity among HIV-exposed and unexposed children in South Africa is insufficient to protect against severe liver complications associated with HAV infection later in adulthood.<\/jats:p>","DOI":"10.3390\/vaccines12111276","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T06:10:48Z","timestamp":1731478248000},"page":"1276","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis A Seroprevalence Among HIV-Exposed and Unexposed Pediatric Populations in South Africa"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3913-0457","authenticated-orcid":false,"given":"Edina","family":"Amponsah-Dacosta","sequence":"first","affiliation":[{"name":"Vaccines for Africa Initiative, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7384-4752","authenticated-orcid":false,"given":"Lufuno","family":"Ratshisusu","sequence":"additional","affiliation":[{"name":"HIV and Hepatitis Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorato M.","family":"Modise","sequence":"additional","affiliation":[{"name":"HIV and Hepatitis Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ntombifuthi","family":"Blose","sequence":"additional","affiliation":[{"name":"Health Systems Trust, Durban 4001, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omphile E.","family":"Simani","sequence":"additional","affiliation":[{"name":"HIV and Hepatitis Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5101-5198","authenticated-orcid":false,"given":"Selokela G.","family":"Selabe","sequence":"additional","affiliation":[{"name":"HIV and Hepatitis Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa"},{"name":"National Health Laboratory Service, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4943-9762","authenticated-orcid":false,"given":"Benjamin M.","family":"Kagina","sequence":"additional","affiliation":[{"name":"Vaccines for Africa Initiative, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudzani","family":"Muloiwa","sequence":"additional","affiliation":[{"name":"Vaccines for Africa Initiative, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"},{"name":"Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2023, October 24). WHO Position Paper on Hepatitis A Vaccines\u2014October 2022. Available online: https:\/\/www.who.int\/publications-detail-redirect\/who-wer9740-493-512."},{"key":"ref_2","unstructured":"World Health Organization (2024, January 07). Global Hepatitis Report. Available online: https:\/\/www.who.int\/publications-detail-redirect\/9789241565455."},{"key":"ref_3","unstructured":"The Institute for Health Metrics and Evaluation (2024, January 07). Acute Hepatitis A\u2014Level 4 Cause. Available online: https:\/\/www.healthdata.org\/research-analysis\/diseases-injuries-risks\/factsheets\/2021-acute-hepatitis-level-4-disease."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"a031708","DOI":"10.1101\/cshperspect.a031708","article-title":"Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis A","volume":"8","author":"Shin","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2017.08.034","article-title":"Type A Viral Hepatitis: A Summary and Update on the Molecular Virology, Epidemiology, Pathogenesis and Prevention","volume":"68","author":"Lemon","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02560513","article-title":"Decline of Hepatitis A Antibodies during the First 7 Months of Life in Full-Term and Preterm Infants","volume":"27","author":"Linder","year":"1999","journal-title":"Infection"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4269\/ajtmh.2005.73.457","article-title":"Decline of Maternal Hepatitis A Antibodies during the First 2 Years of Life in Infants Born in Turkey","volume":"73","author":"Derya","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1651-2227.2002.tb02849.x","article-title":"Decline of Maternal Hepatitis A Virus Antibody Levels in Infants","volume":"91","author":"Avanzini","year":"2002","journal-title":"Acta Paediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00006454-200204000-00017","article-title":"Kinetics of Maternal Hepatitis A Antibody Decay in Infants: Implications for Vaccine Use","volume":"21","author":"Lieberman","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Migueres, M., Lhomme, S., and Izopet, J. (2021). Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment. Viruses, 13.","DOI":"10.3390\/v13101900"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Patterson, J., Abdullahi, L., Hussey, G.D., Muloiwa, R., and Kagina, B.M. (2019). A Systematic Review of the Epidemiology of Hepatitis A in Africa. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4235-5"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Haeri Mazanderani, A., Motaze, N.V., McCarthy, K., Suchard, M., and du Plessis, N.M. (2019). Hepatitis A Virus Seroprevalence in South Africa\u2014Estimates Using Routine Laboratory Data, 2005\u20132015. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216033"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7196\/SAMJ.2019.v109i5.13410","article-title":"Hepatitis A Seroprevalence in Western Cape Province, South Africa: Are We in Epidemiological Transition?","volume":"109","author":"Enoch","year":"2019","journal-title":"S. Afr. Med. J."},{"key":"ref_14","unstructured":"National Department of Health National (2023, October 24). Guidelines for the Management of Viral Hepatitis, Available online: https:\/\/knowledgehub.health.gov.za\/elibrary\/national-guidelines-management-viral-hepatitis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Prabdial-Sing, N., Motaze, V., Manamela, J., McCarthy, K., and Suchard, M. (2021). Establishment of Outbreak Thresholds for Hepatitis A in South Africa Using Laboratory Surveillance, 2017\u20132020. Viruses, 13.","DOI":"10.3390\/v13122470"},{"key":"ref_16","first-page":"43","article-title":"An Overview of Hepatitis A at Tygerberg Children\u2019s Hospital","volume":"2","author":"Solomons","year":"2008","journal-title":"S. Afr. J. Child Health"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Patterson, J., Cleary, S., Silal, S.P., Hussey, G.D., Enoch, A., Korsman, S., Goddard, E., Setshedi, M., Spearman, W.C., and Kagina, B.M. (2022). A Retrospective Study Assessing the Clinical Outcomes and Costs of Acute Hepatitis A in Cape Town, South Africa. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-021-06993-w"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.3748\/wjg.v23.i20.3589","article-title":"Hepatitis A Virus Infection and Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Patients: A Review","volume":"23","author":"Lin","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"du Plessis, N.M., Haeri Mazanderani, A., Motaze, N.V., Ngobese, M., and Avenant, T. (2022). Hepatitis A Virus Seroprevalence among Children and Adolescents in a High-Burden HIV Setting in Urban South Africa. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-25064-x"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/S2214-109X(19)30448-6","article-title":"Global Estimates of Children HIV Exposed and Uninfected in the Evolving HIV Epidemic: 2000 to 2018","volume":"8","author":"Slogrove","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Slogrove, A.L., Goetghebuer, T., Cotton, M.F., Singer, J., and Bettinger, J.A. (2016). Pattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and Children. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00164"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"du Toit, L.D.V., Prinsloo, A., Steel, H.C., Feucht, U., Louw, R., and Rossouw, T.M. (2023). Immune and Metabolic Alterations in Children with Perinatal HIV Exposure. Viruses, 15.","DOI":"10.3390\/v15020279"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1016\/j.vaccine.2015.06.076","article-title":"Hepatitis B Virus Infection in HIV-Exposed Infants in the Western Cape, South Africa","volume":"33","author":"Chotun","year":"2015","journal-title":"Vaccine"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Tamandjou Tchuem, C., Cotton, M.F., Nel, E., Tedder, R., Preiser, W., Violari, A., Bobat, R., Hovind, L., Aaron, L., and Montepiedra, G. (2020). Viral Hepatitis B and C in HIV-Exposed South African Infants. BMC Pediatr., 20.","DOI":"10.1186\/s12887-020-02479-x"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Abu-Raya, B., Kollmann, T.R., Marchant, A., and MacGillivray, D.M. (2016). The Immune System of HIV-Exposed Uninfected Infants. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00383"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/INF.0000000000001132","article-title":"Incidence and Diagnosis of Pertussis in South African Children Hospitalized With Lower Respiratory Tract Infection","volume":"35","author":"Muloiwa","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0253-7176.116232","article-title":"How to Calculate Sample Size for Different Study Designs in Medical Research?","volume":"35","author":"Charan","year":"2013","journal-title":"Indian. J. Psychol. Med."},{"key":"ref_28","unstructured":"Dhand, N.K., and Khatkar, M.S. (2024, January 30). Sample Size Calculator for Estimating a Single Proportion. Available online: https:\/\/statulator.com\/SampleSize\/ss1P.html."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJM199902253400802","article-title":"A Multistate, Foodborne Outbreak of Hepatitis A. National Hepatitis A Investigation Team","volume":"340","author":"Hutin","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1086\/427992","article-title":"Hepatitis A Molecular Epidemiology in the United States, 1996\u20131997: Sources of Infection and Implications of Vaccination Policy","volume":"191","author":"Nainan","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_31","unstructured":"(2023, January 12). R Core Team R: A Language and Environment for Statistical Computing. Available online: https:\/\/www.r-project.org\/."},{"key":"ref_32","unstructured":"Tableau Software (Tableau Desktop 2024, 2024). Tableau Desktop 2024, version 2024.1.0."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2021.01.008","article-title":"Framework for the Treatment and Reporting of Missing Data in Observational Studies: The Treatment And Reporting of Missing Data in Observational Studies Framework","volume":"134","author":"Lee","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2223\/1337","article-title":"The prevalence of hepatitis A antibodies in HIV exposed and\/or infected children and adolescents","volume":"81","author":"Machado","year":"2005","journal-title":"J. Pediatr."},{"key":"ref_35","unstructured":"(2024, January 17). Statistics South Africa Living Conditions of Households in South Africa, 2014\/2015, Available online: https:\/\/www.statssa.gov.za\/publications\/P0310\/P03102014.pdf."},{"key":"ref_36","unstructured":"(2024, January 17). Statistics South Africa General Household Survey (GHS), Available online: https:\/\/www.statssa.gov.za\/publications\/P0318\/P03182021.pdf."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ariyarathna, N., and Abeysena, C. (2020). Risk Factors for Viral Hepatitis A Infection in Gampaha District, Sri Lanka: An Unmatched Case Control Study. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-08490-2"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kunanitthaworn, N., Mueangmo, O., Saheng, J., Wongjak, W., Lertsiriladakul, T., Chaito, T., Nantarat, P., and Sudjaritruk, T. (2023). Seroprevalence of Hepatitis A Virus Antibodies among Children and Adolescents Living in Northern Thailand: An Implication for Hepatitis A Immunization. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-44643-0"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/11\/1276\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:31:17Z","timestamp":1760113877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/11\/1276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["vaccines12111276"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12111276","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2024,11,13]]}}}